DK1268387T3 - Specifikke saltformer af triphenylethylenderivater som selektive östrogenreceptormodulatorer - Google Patents

Specifikke saltformer af triphenylethylenderivater som selektive östrogenreceptormodulatorer

Info

Publication number
DK1268387T3
DK1268387T3 DK01926670T DK01926670T DK1268387T3 DK 1268387 T3 DK1268387 T3 DK 1268387T3 DK 01926670 T DK01926670 T DK 01926670T DK 01926670 T DK01926670 T DK 01926670T DK 1268387 T3 DK1268387 T3 DK 1268387T3
Authority
DK
Denmark
Prior art keywords
estrogen receptor
salt forms
receptor modulators
selective estrogen
specific salt
Prior art date
Application number
DK01926670T
Other languages
Danish (da)
English (en)
Inventor
Gary A Cain
Reginald O Cann
Christopher A Teleha
Denette K Murphy
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Application granted granted Critical
Publication of DK1268387T3 publication Critical patent/DK1268387T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01926670T 2000-04-05 2001-04-05 Specifikke saltformer af triphenylethylenderivater som selektive östrogenreceptormodulatorer DK1268387T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19458000P 2000-04-05 2000-04-05
PCT/US2001/011169 WO2001077055A2 (fr) 2000-04-05 2001-04-05 Formes de sels specifiques de derives de triphenylethylene utilises comme modulateurs selectifs des recepteurs d'oestrogenes

Publications (1)

Publication Number Publication Date
DK1268387T3 true DK1268387T3 (da) 2004-10-18

Family

ID=22718126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01926670T DK1268387T3 (da) 2000-04-05 2001-04-05 Specifikke saltformer af triphenylethylenderivater som selektive östrogenreceptormodulatorer

Country Status (12)

Country Link
US (1) US6417394B2 (fr)
EP (1) EP1268387B1 (fr)
JP (1) JP2004507452A (fr)
AT (1) ATE269291T1 (fr)
AU (2) AU5319101A (fr)
CA (1) CA2403263A1 (fr)
DE (1) DE60103867T2 (fr)
DK (1) DK1268387T3 (fr)
ES (1) ES2222988T3 (fr)
PT (1) PT1268387E (fr)
TR (1) TR200401601T4 (fr)
WO (1) WO2001077055A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005528320A (ja) 2001-08-11 2005-09-22 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 選択的なエストロゲン受容体モジュレーター
EP1692127B1 (fr) 2003-10-08 2008-07-02 Smithkline Beecham Corporation Composes de triphenylethylene comme modulateurs selectifs du recepteur des oestrogenes
US7196119B2 (en) * 2003-10-21 2007-03-27 The Regents Of The University Of California Development of new selective estrogen receptor modulators
US7425580B2 (en) * 2004-05-19 2008-09-16 Wyeth (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
EP1951217A4 (fr) * 2005-11-22 2009-08-12 Smithkline Beecham Corp Composes chimiques
WO2009120999A2 (fr) * 2008-03-28 2009-10-01 Olema Pharmaceuticals, Inc. Utilisation d’un promédicament d’endoxifène dans le traitement du cancer de la poitrine
RU2666530C2 (ru) * 2012-01-12 2018-09-11 Йейл Юниверсити Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью е3 убиквитин лигазы

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9208511D0 (en) * 1991-05-09 1992-06-03 Ici Plc Compounds
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
NZ502738A (en) * 1997-08-15 2002-06-28 Univ Duke Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives

Also Published As

Publication number Publication date
ATE269291T1 (de) 2004-07-15
EP1268387B1 (fr) 2004-06-16
PT1268387E (pt) 2004-09-30
DE60103867T2 (de) 2005-06-30
US6417394B2 (en) 2002-07-09
WO2001077055A2 (fr) 2001-10-18
CA2403263A1 (fr) 2001-10-18
WO2001077055A3 (fr) 2002-05-30
JP2004507452A (ja) 2004-03-11
DE60103867D1 (de) 2004-07-22
AU5319101A (en) 2001-10-23
ES2222988T3 (es) 2005-02-16
AU2001253191B2 (en) 2006-03-02
US20020004496A1 (en) 2002-01-10
TR200401601T4 (tr) 2004-08-23
EP1268387A2 (fr) 2003-01-02

Similar Documents

Publication Publication Date Title
DK1353672T3 (da) Syntese af 4-amino-thalidomidenantiomerer
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
WO2003016270A3 (fr) Modulateurs selectifs de recepteur d'oestrogene
NO20031687D0 (no) Veksthormonsekretagoger
WO2006126939A8 (fr) Nouveaux 8-sulfonylamino-3 aminosubstitues chroman ou derives de tetrahydronaphtalene modulant le recepteur 5-ht6
DK1436257T3 (da) Oxim-analogica af 1-alpha, 25-dihydroxy-vitamin-D3 med ringe kalcemisk virkning
CY1109989T1 (el) 3,4-di-υποκαθισταμενες cyclobutene-1,2-diones ως συνδετες του υποδοχεα των cxc-χημειοκινων
DE69935335D1 (de) Pyrazole als modulatoren des östrogenrezeptors
EA200601798A1 (ru) Замещенные соединения морфолина для лечения расстройств центральной нервной системы
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
SE0302760D0 (sv) New compounds
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
DK1268387T3 (da) Specifikke saltformer af triphenylethylenderivater som selektive östrogenreceptormodulatorer
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
ATE276995T1 (de) Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren
MXPA01008347A (es) Compuestos quimicos.
BRPI0412636A (pt) imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer
DE602006005254D1 (de) Neue chinolinverbindungen, die dazu in der lage sind, sich an den cb2-rezeptor zu binden
AR047810A1 (es) Proceso quimico
WO2003027061A3 (fr) Agonistes muscariniques
GB0425548D0 (en) Radiolabelled ligands
UA74430C2 (uk) Похідні фенілгетероциклічних етерів як інгібітори зворотного захоплення серотоніну
RS56004A (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
WO2004087673A3 (fr) Analogues de migrastatine et leurs utilisations
SG85165A1 (en) Alpha, beta-unsaturated ketones